Literature DB >> 26774327

Decision support systems for personalized and participative radiation oncology.

Philippe Lambin1, Jaap Zindler2, Ben G L Vanneste2, Lien Van De Voorde2, Daniëlle Eekers2, Inge Compter2, Kranthi Marella Panth2, Jurgen Peerlings2, Ruben T H M Larue2, Timo M Deist2, Arthur Jochems2, Tim Lustberg2, Johan van Soest2, Evelyn E C de Jong2, Aniek J G Even2, Bart Reymen2, Nicolle Rekers2, Marike van Gisbergen2, Erik Roelofs2, Sara Carvalho2, Ralph T H Leijenaar2, Catharina M L Zegers2, Maria Jacobs2, Janita van Timmeren2, Patricia Brouwers2, Jonathan A Lal2, Ludwig Dubois2, Ala Yaromina2, Evert Jan Van Limbergen2, Maaike Berbee2, Wouter van Elmpt2, Cary Oberije2, Bram Ramaekers2, Andre Dekker2, Liesbeth J Boersma2, Frank Hoebers2, Kim M Smits2, Adriana J Berlanga2, Sean Walsh2.   

Abstract

A paradigm shift from current population based medicine to personalized and participative medicine is underway. This transition is being supported by the development of clinical decision support systems based on prediction models of treatment outcome. In radiation oncology, these models 'learn' using advanced and innovative information technologies (ideally in a distributed fashion - please watch the animation: http://youtu.be/ZDJFOxpwqEA) from all available/appropriate medical data (clinical, treatment, imaging, biological/genetic, etc.) to achieve the highest possible accuracy with respect to prediction of tumor response and normal tissue toxicity. In this position paper, we deliver an overview of the factors that are associated with outcome in radiation oncology and discuss the methodology behind the development of accurate prediction models, which is a multi-faceted process. Subsequent to initial development/validation and clinical introduction, decision support systems should be constantly re-evaluated (through quality assurance procedures) in different patient datasets in order to refine and re-optimize the models, ensuring the continuous utility of the models. In the reasonably near future, decision support systems will be fully integrated within the clinic, with data and knowledge being shared in a standardized, dynamic, and potentially global manner enabling truly personalized and participative medicine.
Copyright © 2016. Published by Elsevier B.V.

Entities:  

Keywords:  Decision support systems; Prediction models; Radiotherapy; Shared decision making

Mesh:

Year:  2016        PMID: 26774327     DOI: 10.1016/j.addr.2016.01.006

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  36 in total

Review 1.  Radiomics: the bridge between medical imaging and personalized medicine.

Authors:  Philippe Lambin; Ralph T H Leijenaar; Timo M Deist; Jurgen Peerlings; Evelyn E C de Jong; Janita van Timmeren; Sebastian Sanduleanu; Ruben T H M Larue; Aniek J G Even; Arthur Jochems; Yvonka van Wijk; Henry Woodruff; Johan van Soest; Tim Lustberg; Erik Roelofs; Wouter van Elmpt; Andre Dekker; Felix M Mottaghy; Joachim E Wildberger; Sean Walsh
Journal:  Nat Rev Clin Oncol       Date:  2017-10-04       Impact factor: 66.675

2.  Toward a model-based patient selection strategy for proton therapy: External validation of photon-derived normal tissue complication probability models in a head and neck proton therapy cohort.

Authors:  Pierre Blanchard; Andrew J Wong; G Brandon Gunn; Adam S Garden; Abdallah S R Mohamed; David I Rosenthal; Joseph Crutison; Richard Wu; Xiaodong Zhang; X Ronald Zhu; Radhe Mohan; Mayankkumar V Amin; C David Fuller; Steven J Frank
Journal:  Radiother Oncol       Date:  2016-09-15       Impact factor: 6.280

3.  Prospects and challenges for clinical decision support in the era of big data.

Authors:  Issam El Naqa; Michael R Kosorok; Judy Jin; Michelle Mierzwa; Randall K Ten Haken
Journal:  JCO Clin Cancer Inform       Date:  2018-11-09

Review 4.  Advances in Clinical Decision Support: Highlights of Practice and the Literature 2015-2016.

Authors:  R A Jenders
Journal:  Yearb Med Inform       Date:  2017-09-11

5.  An artificial intelligence framework integrating longitudinal electronic health records with real-world data enables continuous pan-cancer prognostication.

Authors:  Olivier Morin; Martin Vallières; Steve Braunstein; Jorge Barrios Ginart; Taman Upadhaya; Henry C Woodruff; Alex Zwanenburg; Avishek Chatterjee; Javier E Villanueva-Meyer; Gilmer Valdes; William Chen; Julian C Hong; Sue S Yom; Timothy D Solberg; Steffen Löck; Jan Seuntjens; Catherine Park; Philippe Lambin
Journal:  Nat Cancer       Date:  2021-07-22

6.  Reproducibility and non-redundancy of radiomic features extracted from arterial phase CT scans in hepatocellular carcinoma patients: impact of tumor segmentation variability.

Authors:  Qingtao Qiu; Jinghao Duan; Zuyun Duan; Xiangjuan Meng; Changsheng Ma; Jian Zhu; Jie Lu; Tonghai Liu; Yong Yin
Journal:  Quant Imaging Med Surg       Date:  2019-03

Review 7.  Machine Learning and Imaging Informatics in Oncology.

Authors:  Huan-Hsin Tseng; Lise Wei; Sunan Cui; Yi Luo; Randall K Ten Haken; Issam El Naqa
Journal:  Oncology       Date:  2018-11-23       Impact factor: 2.935

Review 8.  Optimal design and patient selection for interventional trials using radiogenomic biomarkers: A REQUITE and Radiogenomics consortium statement.

Authors:  Dirk De Ruysscher; Gilles Defraene; Bram L T Ramaekers; Philippe Lambin; Erik Briers; Hilary Stobart; Tim Ward; Søren M Bentzen; Tjeerd Van Staa; David Azria; Barry Rosenstein; Sarah Kerns; Catharine West
Journal:  Radiother Oncol       Date:  2016-12-12       Impact factor: 6.280

9.  Modeling-Based Decision Support System for Radical Prostatectomy Versus External Beam Radiotherapy for Prostate Cancer Incorporating an In Silico Clinical Trial and a Cost-Utility Study.

Authors:  Yvonka van Wijk; Bram Ramaekers; Ben G L Vanneste; Iva Halilaj; Cary Oberije; Avishek Chatterjee; Tom Marcelissen; Arthur Jochems; Henry C Woodruff; Philippe Lambin
Journal:  Cancers (Basel)       Date:  2021-05-29       Impact factor: 6.639

Review 10.  Creation of clinical algorithms for decision-making in oncology: an example with dose prescription in radiation oncology.

Authors:  Fabio Dennstädt; Theresa Treffers; Thomas Iseli; Cédric Panje; Paul Martin Putora
Journal:  BMC Med Inform Decis Mak       Date:  2021-07-12       Impact factor: 2.796

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.